Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. blood processing
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Blood Processing Articles & Analysis

23 news found

Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

Tethis S.p.A. Collaborates with Weill Cornell Medicine to Advance Cellular Residual Disease Monitoring in Early-Stage Breast Cancer

About See.d See.d is the first universal blood sample preparator for liquid biopsy analysis, automating and standardizing preparation at the point of collection. It stabilizes the cellular fraction on nanocoated SmartBioSurface® slides for detecting rare cells like CTCs, while plasma is made available for the analysis of cfDNA, cfRNA/miRNA, proteins, metabolites, and ...

ByTethis S.p.A


XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory Angina

XyloCor Therapeutics Commences Phase 2 Component of Phase 1/2 EXACT Clinical Study of XC001 Gene Therapy for Refractory Angina

“With a unique mechanism of action that restores blood flow to the heart via the creation of new blood vessels, XC001 represents a novel therapeutic approach for patients who have exhausted other medical and surgical options. ...

ByXyloCor Therapeutics


Why Innovation in Blood Testing Matters

Why Innovation in Blood Testing Matters

What are the challenges with traditional blood testing for both payers and members? Traditional blood testing has not kept up with consumer preferences and innovations in health care. ...

ByBabson Diagnostics


It All Starts With Patient Safety at Medovate

It All Starts With Patient Safety at Medovate

Application of good design and quality engineering processes can support the development of technologies which have a positive impact on patient safety. ...

ByMedovate


Members of Congress Urge CMS to Take Action to Reduce Preventable False-Positive Diagnostic Test Results for Sepsis

Members of Congress Urge CMS to Take Action to Reduce Preventable False-Positive Diagnostic Test Results for Sepsis

“By embracing an innovative approach to blood culture processing, CMS can advance the accuracy of the diagnosis of blood stream infections including sepsis to improve patient outcomes and avoid costly complications from misdiagnosis,” said Representative Gus Bilirakis. ...

ByMagnolia Medical Technologies


BrainScope Completes Agreement with 18,000 Member Yankee Alliance

BrainScope Completes Agreement with 18,000 Member Yankee Alliance

The assessment uses EEG derived algorithms so there is no blood draw or processing in a lab—it is truly point-of-care and takes just minutes from patient prep to results. ...

ByBrainScope Company, Inc.


XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease

XyloCor Therapeutics Completes Oversubscribed $41.9 Million Series A Financing To Advance Novel Gene Therapy Pipeline For Coronary Artery Disease

About XC001 XC001 is an investigational gene therapy designed to promote the growth of new blood vessels in the heart, with these new blood vessels bypassing diseased blood vessels and improving blood flow in the heart. ...

ByXyloCor Therapeutics


Seventh Sense Blood Collection Technology Key Part of Gateway Genomics’ SneakPeek Snap for Gender DNA Test

Seventh Sense Blood Collection Technology Key Part of Gateway Genomics’ SneakPeek Snap for Gender DNA Test

Making blood collection simpler, more convenient, and more comfortable. That’s our mission, and we are thrilled to share that our partner, Gateway Genomics, is leveraging our TAP II blood collection technology in its product offering, the SneakPeek Early Gender DNA Test. Called SneakPeek Snap, the blood collection device is included as part ...

BySeventh Sense Biosystems Inc.


C2N Diagnostics Statement on FDA Accelerated Approval of Aducanumab forAlzheimer’s Treatment

C2N Diagnostics Statement on FDA Accelerated Approval of Aducanumab forAlzheimer’s Treatment

Starting with the PrecivityAD™ blood test, it’s possible to identify brain amyloid plaques from a single sample of blood and to aid in the early diagnosis of Alzheimer’s disease. ...

ByC2N Diagnostics


Accelerate Diagnostics Receives CARB-X Award to Develop Rapid Optical Imaging Technology for Sepsis and Antibiotic-Resistant Infections

Accelerate Diagnostics Receives CARB-X Award to Develop Rapid Optical Imaging Technology for Sepsis and Antibiotic-Resistant Infections

Bacterial identification could potentially be within 15 minutes from a positive blood culture with minimal sample processing. The technology has demonstrated high sensitivity and specificity and is able to identify a wide range of pathogens which is currently not possible with panel tests. ...

ByAccelerate Diagnostics, Inc.


Abram Scientific Secures $1 Million National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II Grant

Abram Scientific Secures $1 Million National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II Grant

The platform utilizes proprietary technology for fast and highly accurate measurement of blood viscoelasticity and density, characterizing the entire blood coagulation cascade from blood clot formation to lysis, enabling the detection of blood clotting or bleeding disorders and guiding the use of therapy for optimal coagulation ...

ByAbram Scientific, Inc.


BrainScope Launches Next-Gen Medical Device: First and only FDA-cleared system for true point-of-care assessment of both concussion and brain bleeds now includes Concussion Index

BrainScope Launches Next-Gen Medical Device: First and only FDA-cleared system for true point-of-care assessment of both concussion and brain bleeds now includes Concussion Index

The company's disposable headset connects to its handheld device which acquires, processes and analyzes thousands of brain activity based physiological parameters, transforming them into a single index by using artificial intelligence algorithms. ...

ByBrainScope Company, Inc.


Seventh Sense Biosystems Expands to European Markets for Consumer Blood Collection with TAP II CE Marking

Seventh Sense Biosystems Expands to European Markets for Consumer Blood Collection with TAP II CE Marking

The process is simple. A patient places TAP II on their upper arm and presses a button on the device to begin blood collection. The process to collect blood takes only two to three minutes. After collection is complete, the device is sent back to a lab for analysis. “We believe that the simple blood ...

BySeventh Sense Biosystems Inc.


Abram Scientific Secures $2.9 Million US Army Medical Research Grant to Deliver a Portable Viscoelastic, Blood Coagulation Diagnostic Platform for COVID-19 associated Coagulopathy Management

Abram Scientific Secures $2.9 Million US Army Medical Research Grant to Deliver a Portable Viscoelastic, Blood Coagulation Diagnostic Platform for COVID-19 associated Coagulopathy Management

The platform utilizes proprietary technology for fast and highly accurate measurement of blood viscoelasticity and density, characterizing the entire blood coagulation cascade from blood clot formation to lysis, enabling the detection of blood clotting or bleeding disorders and guiding the use of therapy for optimal coagulation ...

ByAbram Scientific, Inc.


Ground-breaking New Medical Device Saving Lives and Resources During Pandemic

Ground-breaking New Medical Device Saving Lives and Resources During Pandemic

” “This frees up much-needed hospital beds, moves patients out of our Emergency Department, and allows us to focus on the more critically ill without having to wait for the traditional blood test, a process which can take up to an hour,” Dr. Ramirez added. Doctors can use the AGM100® to continue to monitor lung function at a micro level ...

ByMediPines


Alzheimer’s Breakthrough: C2N First to Offer a Widely Accessible Blood Test

Alzheimer’s Breakthrough: C2N First to Offer a Widely Accessible Blood Test

C2N analyzes the blood in its specialized laboratory facility using mass spectrometry to measure the concentrations of amyloid beta 42 and 40 (Aβ42 and Aβ40), and the presence of apolipoprotein E (ApoE) isoforms in blood. The analysis process is automated and allows for C2N to process samples in a routine and repeatable ...

ByC2N Diagnostics


Understanding the different types of COVID-19 Testing

Understanding the different types of COVID-19 Testing

Pros of Viral Tests: Able to tell if someone is infected before antibodies form or symptom appears, so ideal for early detection and asymptomatic detection Gives the ability to gather specific data like how dangerous the virus is for different demographics Can follow infected people to see when they are no longer contagious Cons of Viral Tests: Requires expert lab personnel More ...

ByMiraDx


AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

Clinically, the pericardium of cattle or pigs is already used to replace human heart valves or to reconstruct blood vessels. However, the processing of animal tissue is expensive and does not guarantee long-term mechanical stability. ...

ByAdjuCor GmbH


DiamiR Receives Award from Alzheimer`s Drug Discovery Foundation to Accelerate Development of microRNA Biomarkers for Alzheimer`s Disease

DiamiR Receives Award from Alzheimer`s Drug Discovery Foundation to Accelerate Development of microRNA Biomarkers for Alzheimer`s Disease

DiamiR, a developer of innovative blood-based diagnostic tests for neurodegenerative and other diseases, announced today a $492,000 award in support of the project entitled "Circulating brain-enriched microRNAs as peripheral biomarkers of neurodegeneration." ...

ByDiamiR


Gauss Surgical Announces $12.6 Million Series B Financing

Gauss Surgical Announces $12.6 Million Series B Financing

Conversely, underestimation of blood loss has been recognized as one of largest factors driving post-partum hemorrhage due to delayed recognition and intervention. ...

ByGauss Surgical

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT